4//SEC Filing
DREYER DAVID C 4
Accession 0001596771-19-000055
CIK 0001610092other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:15 PM ET
Size
6.6 KB
Accession
0001596771-19-000055
Insider Transaction Report
Form 4
DREYER DAVID C
Director
Transactions
- Sale
Common Stock
2019-06-04$4.85/sh−1,274$6,185→ 40,987 total - Award
Common Stock
2019-06-03+20,674→ 42,261 total
Footnotes (3)
- [F1]The shares of restricted stock were granted in connection with the Issuer's non-employee director compensation program.
- [F2]The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the vesting of previously granted restricted stock.
- [F3]The price represents the weighted average price of the multiple transactions reported on this line. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
Diplomat Pharmacy, Inc.
CIK 0001610092
Entity typeother
Related Parties
1- filerCIK 0001203607
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:15 PM ET
- Size
- 6.6 KB